DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Jagsonpal Pharmaceuticals Limited — Press Release

NSE 35 min ago·29 Jul 2026, 12:54 pm

Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Limited has announced that it will release its unaudited financial results for the quarter ended June 30, 2026. The company has submitted a formal press release to the stock exchange to inform investors about the timing of this disclosure.

This announcement is significant for shareholders as it provides an early glimpse into the company's operational performance during the first quarter of the fiscal year. Investors will be closely watching the figures to assess the company's growth trajectory and financial health.

Market participants should await the official release of the results to analyze the company's performance against market expectations. The data will be crucial for evaluating the stock's short-term potential and the company's strategic direction.